Achieving CAR T-cell Therapy Health System Readiness

56 Pages

This report assesses health system readiness to deliver CAR T-cell therapies across seven countries. It analyzes patient referral, reimbursement, infrastructure, treatment capacity, and long-term monitoring challenges. Despite strong clinical efficacy, access remains uneven due to operational complexity and resource constraints. The report highlights best practices and policy actions to improve coordination, expand capacity, and ensure equitable access, supporting broader adoption of advanced cell therapies.

Join for free to read

Ebook Pathways to Overcome Challenges to CAR T-cell Therapy Readiness

White Paper The Path to CAR T–Cell Therapy

Case Study Cryopreservation Best Practices for CAR-T Cell Storage

White Paper Safety, Efficacy, Cost: The Trifecta for Increasing Access to…

More from IQVIA

Ebook Pathways to Overcome Challenges to CAR T-cell Therapy Readiness

White Paper The Path to CAR T–Cell Therapy

White Paper Evolving Landscape of Immuno-Oncology

Report Oncology Therapy Access in the Era of Personalized Medicine

Report

Achieving CAR T-cell Therapy Health System Readiness

Achieving CAR T-cell Therapy Health System Readiness

You Might Also Like

More from IQVIA